We are live on
!
Find out more
CAPTRUST Financial Advisors Portfolio holdings
AUM
$65.5B
1-Year Est. Return
24.25%
This Fund
S&P 500
This Quarter
Est. Return
+14.23%
1 Year Est. Return
+24.25%
3 Year Est. Return
+72.65%
5 Year Est. Return
+85.27%
10 Year Est. Return
+285.21%
AUM
$65.5B
AUM Growth
+$8.17B
(+14%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
3.16%
Top 10 Holdings %
Top 10 Hldgs %
26.79%
Holding
3,427
New
411
Increased
1,662
Reduced
1,039
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$256M |
| 2 |
Broadcom
AVGO
|
+$177M |
| 3 |
NVIDIA
NVDA
|
+$158M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$156M |
| 5 |
Microsoft
MSFT
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$242M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$121M |
| 3 |
ResMed
RMD
|
+$90.9M |
| 4 |
Vanguard International High Dividend Yield ETF
VYMI
|
+$83.3M |
| 5 |
ScottsMiracle-Gro
SMG
|
+$71.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.01% |
| 2 | Technology | 16.85% |
| 3 | Financials | 7.2% |
| 4 | Industrials | 4.88% |
| 5 | Healthcare | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Recursion Pharmaceuticals
RXRX
$1.84B
| $138K | ﹤0.01% |
37,672
+18,774
| +99% | +$62.5K |
|
|
PDO
2977
PIMCO Dynamic Income Opportunities Fund
PDO
$1.82B
| $138K | ﹤0.01% |
+10,439
| New | +$137K |
|
|
REGS
2978
Columbia Large Cap Growth ETF
REGS
$65.5M
| $137K | ﹤0.01% |
12,139
| – | – |
|
2979
Genworth Financial
GNW
$3.94B
| $136K | ﹤0.01% |
14,411
+2,960
| +26% | +$26.3K |
|
2980
Ecovyst
ECVT
$1.11B
| $136K | ﹤0.01% |
+10,908
| New | +$148K |
|
2981
Invesco Value Municipal Income Trust
IIM
$580M
| $135K | ﹤0.01% |
10,626
-851
| -7% | -$10.5K |
|
|
MIN
2982
Aberdeen Intermediate Income Fund
MIN
$273M
| $135K | ﹤0.01% |
54,647
-13,715
| -20% | -$33.8K |
|
2983
Kosmos Energy
KOS
$1.7B
| $133K | ﹤0.01% |
63,186
+9,247
| +17% | +$25.7K |
|
|
NGEN
2984
NervGen Pharma
NGEN
$235M
| $133K | ﹤0.01% |
64,423
+2,056
| +3% | +$6.38K |
|
2985
Repay Holdings
RPAY
$305M
| $132K | ﹤0.01% |
31,472
+6,911
| +28% | +$24K |
|
2986
Sprinklr
CXM
$1.29B
| $132K | ﹤0.01% |
25,503
+9,442
| +59% | +$50.2K |
|
|
IRD
2987
Opus Genetics
IRD
$361M
| $132K | ﹤0.01% |
32,000
| – | – |
|
2988
Rocket Pharmaceuticals
RCKT
$407M
| $131K | ﹤0.01% |
38,365
+5,586
| +17% | +$18.6K |
|
2989
Tonix Pharmaceuticals
TNXP
$226M
| $131K | ﹤0.01% |
+10,233
| New | +$132K |
|
2990
Savers
SVV
$1.57B
| $129K | ﹤0.01% |
+12,793
| New | +$111K |
|
|
BMNR
2991
BitMine Immersion Technologies
BMNR
$14.9B
| $127K | ﹤0.01% |
9,545
-1,719
| -15% | -$33.2K |
|
2992
Baytex Energy
BTE
$3.42B
| $126K | ﹤0.01% |
+31,490
| New | +$145K |
|
2993
Douglas Elliman
DOUG
$162M
| $126K | ﹤0.01% |
71,023
+7,050
| +11% | +$12.6K |
|
2994
Cerus
CERS
$512M
| $125K | ﹤0.01% |
42,819
+1,604
| +4% | +$3.89K |
|
|
FTMU
2995
Franklin Municipal Income ETF
FTMU
$457M
| $125K | ﹤0.01% |
15,750
+159
| +1% | +$1.25K |
|
2996
Horizon Technology Finance
HRZN
$326M
| $125K | ﹤0.01% |
+26,396
| New | +$114K |
|
2997
ADMA Biologics
ADMA
$2.14B
| $125K | ﹤0.01% |
14,891
-73,141
| -83% | -$667K |
|
2998
Global Net Lease
GNL
$2.1B
| $124K | ﹤0.01% |
13,885
+1,899
| +16% | +$17.8K |
|
2999
Ocular Therapeutix
OCUL
$2.5B
| $124K | ﹤0.01% |
+12,637
| New | +$115K |
|
3000
Mobileye
MBLY
$7.24B
| $123K | ﹤0.01% |
+12,746
| New | +$114K |
|
Similar funds
NAMI
CAPTRUST Financial Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, CAPTRUST Financial Advisors held 3,427 positions worth $65.5B, up 14% from $57.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
CAPTRUST Financial Advisors deployed $2.07B of net new capital in Q2 2026, opening 411 new positions and adding to 1,662 existing holdings. Its largest new stake was Honeywell Aerospace: 167,752 shares worth $37.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $121M trimmed.
- CAPTRUST Financial Advisors's largest Q2 2026 buy was Honeywell Aerospace: 167,752 shares worth $37.1M.
- CAPTRUST Financial Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $256M increase.
- CAPTRUST Financial Advisors's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $121M.
- CAPTRUST Financial Advisors fully exited ExxonMobil in Q2 2026, selling an estimated $242M.
- CAPTRUST Financial Advisors's ten largest holdings make up 27% of its $65.5B portfolio in Q2 2026.
- CAPTRUST Financial Advisors opened 411 new positions and closed 153 in Q2 2026.
- CAPTRUST Financial Advisors's portfolio value rose 14% quarter-over-quarter to $65.5B.
Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.